194
Participants
Start Date
July 23, 2018
Primary Completion Date
September 27, 2019
Study Completion Date
September 27, 2019
Mobile spirometer
Mobile spirometer will be used to measure FEV1 values weekly.
Device sensor
Sensors will be attached to rescue and maintenance inhalers to measure use of rescue medication and maintenance therapy.
Salbutamol
Salbutamol MDI will be given as a rescue medication to be used on an as needed basis in this study.
Activity monitor
Subjects will be required to wear activity monitors daily to record their physical activity.
electronic diary card
Electronic diary card will be completed daily by subjects in COPD cohort.
CAT
Subjects will be required to complete CAT monthly.
ACT
Subjects will be required to complete ACT monthly.
GSK Investigational Site, Danville
Lead Sponsor
Geisinger HealthPlan
INDUSTRY
GlaxoSmithKline
INDUSTRY